Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Upstream Foods is developing a novel fat ingredient to uplevel seafood alternatives
Ebumab is a biotechnology research company utilizing AMT technology in combination with the body’s own immune system to fight cancer.
Myco4Food is a biotechnology research company developing protein alternative novel foods from waste products.
Heka VR is a virtual reality platform developing a novel therapy to aid people suffering from auditory hallucinations.
Solid Therapeutics develops novel cancer therapeutics with dual performance targeting cancer cells and immune cells to treat solid tumors.
Alea provides quick, easy, and safe quantum random number generators.
TriptoBIO is a biotechnology research company developing a platform for producing natural plant compounds.
Rapidemic is a developer of diagnostic kits for infectious diseases.
Notify Therapeutics develops therapies for the treatment of infertility.
Pephexia Therapeutics is a biotechnology company working with the discovery.
Embark Biotech is a biotech company identifying cell surface receptors regulating fat tissue calorie-burning and glucose and lipid uptake.
Prenaital is an AI-driven healthcare company, to revolutionizing maternal care by improving detection & management of high-risk pregnancies.
BioHalo is transforming the halogenated chemicals industry by developing more sustainable and bio-based fluorinated polymers.
Amalus Therapeutics' objective is to significantly improve the lives of those suffering from cancer and fibrotic disorders
Veil.ai offers health data anonymization, synthetic data and pseudonymization services.
Sevenless Therapeutics focus on manufacturing of pharmaceuticals.
Visibuilt is to pioneer sustainable road-building solutions by replacing standard asphalt with cutting-edge, environmentally materials.
Orbit Health focuses on developing an artificial intelligence solution that assists parkinson's disease patients.
Synklino is a developer of a CMV-specific immunotoxin intended to eradicate the cytomegalovirus infection.
Pioneering Resilient Agriculture with Natural Biomolecules
Loma Therapeutics is developing targeted immunotherapy for the effective and safe treatment of HPV infection, dysplasia.
Sundew is a biotechnology company that provides biological services for the treatment of aquatic pests and diseases.
Paragit Solutions develops systems for improving care and diagnosis of movement disorders.
Ousia Pharma focuses on the design and development of pharmacotherapies to improve the health and lives of people living with obesity.
BioInnovation Institute has invested in 141 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
BioInnovation Institute's top investment sectors include Biotechnology, Medical, Health Care, Life Science, Medical Device. The firm invests across 30 different industry categories.
Among tracked funding rounds, Synklino received $32.0M in a Series A round. BioInnovation Institute's total known invested capital is $257.5M.
BioInnovation Institute's average investment size is $2.9M across its portfolio of 141 companies.
Recent BioInnovation Institute portfolio additions include Upstream Foods, Ebumab, Myco4Food, Heka VR, Solid Therapeutics. These companies were founded in 2020 or later.